Clinical Trial Update: The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating atorvastatin for endothelial cell dysfunction in chronic kidney disease with hypercholesterolemia was terminated. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypercholesterolemia

Drugs mentioned

• Lipitor (atorvastatin)

Snippet

Sponsor: Duke University | Conditions: Chronic Kidney Disease, High Cholesterol | Phase 4 | Status: TERMINATED | Results posted: 2014-07-03